Quantitative clinical outcomes of therapy for head and neck lymphedema

Purpose: Head and neck surgery and radiation cause tissue fibrosis that leads to functional limitations and lymphedema. The objective of this study was to determine whether lymphedema therapy after surgery and radiation for head and neck cancer decreases neck circumference, increases cervical range...

Full description

Bibliographic Details
Main Authors: Kaleigh N. Doke, MD, Laine Bowman, MA, OTR, Yelizaveta Shnayder, MD, Xinglei Shen, MD, Mindi TenNapel, PhD, Sufi Mary Thomas, PhD, Prakash Neupane, MD, Hung-Wen Yeh, PhD, Chris E. Lominska, MD
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109418300708
_version_ 1819099982256406528
author Kaleigh N. Doke, MD
Laine Bowman, MA, OTR
Yelizaveta Shnayder, MD
Xinglei Shen, MD
Mindi TenNapel, PhD
Sufi Mary Thomas, PhD
Prakash Neupane, MD
Hung-Wen Yeh, PhD
Chris E. Lominska, MD
author_facet Kaleigh N. Doke, MD
Laine Bowman, MA, OTR
Yelizaveta Shnayder, MD
Xinglei Shen, MD
Mindi TenNapel, PhD
Sufi Mary Thomas, PhD
Prakash Neupane, MD
Hung-Wen Yeh, PhD
Chris E. Lominska, MD
author_sort Kaleigh N. Doke, MD
collection DOAJ
description Purpose: Head and neck surgery and radiation cause tissue fibrosis that leads to functional limitations and lymphedema. The objective of this study was to determine whether lymphedema therapy after surgery and radiation for head and neck cancer decreases neck circumference, increases cervical range of motion, and improves pain scores. Methods and materials: A retrospective review of all patients with squamous cell carcinoma of the oral cavity, oropharynx, or larynx who were treated with high-dose radiation therapy at a single center between 2011 and 2012 was performed. Patients received definitive or postoperative radiation for squamous cell carcinoma of the oral cavity, oropharynx, or larynx. Patients were referred to a single, certified, lymphedema therapist with specialty training in head and neck cancer after completion of radiation treatment and healing of acute toxicity (typically 1-3 months). Patients underwent at least 3 months of manual lymphatic decongestion and skilled fibrotic techniques. Circumferential neck measurements and cervical range of motion were measured clinically at 1, 3, 6, 9, and 12 months after completion of radiation therapy. Pain scores were also recorded. Results: Thirty-four consecutive patients were eligible and underwent a median of 6 months of lymphedema therapy (Range, 3-12 months). Clinically measured total neck circumference decreased in all patients with 1 month of treatment. Cervical rotation increased by 30.2% on the left and 27.9% on the right at 1 month and continued to improve up to 44.6% and 55.3%, respectively, at 12 months. Patients undergoing therapy had improved pain scores from 4.3 at baseline to 2.0 after 1 month. Conclusions: Lymphedema therapy is associated with objective improvements in range of motion, neck circumference, and pain scores in the majority of patients.
first_indexed 2024-12-22T00:55:32Z
format Article
id doaj.art-7f256fe317094cc58309faaf1eda01df
institution Directory Open Access Journal
issn 2452-1094
language English
last_indexed 2024-12-22T00:55:32Z
publishDate 2018-07-01
publisher Elsevier
record_format Article
series Advances in Radiation Oncology
spelling doaj.art-7f256fe317094cc58309faaf1eda01df2022-12-21T18:44:20ZengElsevierAdvances in Radiation Oncology2452-10942018-07-0133366371Quantitative clinical outcomes of therapy for head and neck lymphedemaKaleigh N. Doke, MD0Laine Bowman, MA, OTR1Yelizaveta Shnayder, MD2Xinglei Shen, MD3Mindi TenNapel, PhD4Sufi Mary Thomas, PhD5Prakash Neupane, MD6Hung-Wen Yeh, PhD7Chris E. Lominska, MD8Department of Radiation Oncology, The University of Kansas Health System, Kansas City, Kansas; Corresponding author. Kansas University Medical Center, Department of Radiation Oncology, 3901 Rainbow Boulevard, Kansas City, KS 66160.Overland Park Regional Medical Center, Overland Park, KansasDepartment of Otolaryngology, The University of Kansas Health System, Kansas City, KansasDepartment of Radiation Oncology, The University of Kansas Health System, Kansas City, KansasDepartment of Radiation Oncology, The University of Kansas Health System, Kansas City, KansasDepartment of Otolaryngology, The University of Kansas Health System, Kansas City, KansasDepartment of Medical Oncology, The University of Kansas Health System, Kansas City, KansasDepartment of Biostatistics, The University of Kansas Health System, Kansas City, KansasDepartment of Radiation Oncology, The University of Kansas Health System, Kansas City, KansasPurpose: Head and neck surgery and radiation cause tissue fibrosis that leads to functional limitations and lymphedema. The objective of this study was to determine whether lymphedema therapy after surgery and radiation for head and neck cancer decreases neck circumference, increases cervical range of motion, and improves pain scores. Methods and materials: A retrospective review of all patients with squamous cell carcinoma of the oral cavity, oropharynx, or larynx who were treated with high-dose radiation therapy at a single center between 2011 and 2012 was performed. Patients received definitive or postoperative radiation for squamous cell carcinoma of the oral cavity, oropharynx, or larynx. Patients were referred to a single, certified, lymphedema therapist with specialty training in head and neck cancer after completion of radiation treatment and healing of acute toxicity (typically 1-3 months). Patients underwent at least 3 months of manual lymphatic decongestion and skilled fibrotic techniques. Circumferential neck measurements and cervical range of motion were measured clinically at 1, 3, 6, 9, and 12 months after completion of radiation therapy. Pain scores were also recorded. Results: Thirty-four consecutive patients were eligible and underwent a median of 6 months of lymphedema therapy (Range, 3-12 months). Clinically measured total neck circumference decreased in all patients with 1 month of treatment. Cervical rotation increased by 30.2% on the left and 27.9% on the right at 1 month and continued to improve up to 44.6% and 55.3%, respectively, at 12 months. Patients undergoing therapy had improved pain scores from 4.3 at baseline to 2.0 after 1 month. Conclusions: Lymphedema therapy is associated with objective improvements in range of motion, neck circumference, and pain scores in the majority of patients.http://www.sciencedirect.com/science/article/pii/S2452109418300708
spellingShingle Kaleigh N. Doke, MD
Laine Bowman, MA, OTR
Yelizaveta Shnayder, MD
Xinglei Shen, MD
Mindi TenNapel, PhD
Sufi Mary Thomas, PhD
Prakash Neupane, MD
Hung-Wen Yeh, PhD
Chris E. Lominska, MD
Quantitative clinical outcomes of therapy for head and neck lymphedema
Advances in Radiation Oncology
title Quantitative clinical outcomes of therapy for head and neck lymphedema
title_full Quantitative clinical outcomes of therapy for head and neck lymphedema
title_fullStr Quantitative clinical outcomes of therapy for head and neck lymphedema
title_full_unstemmed Quantitative clinical outcomes of therapy for head and neck lymphedema
title_short Quantitative clinical outcomes of therapy for head and neck lymphedema
title_sort quantitative clinical outcomes of therapy for head and neck lymphedema
url http://www.sciencedirect.com/science/article/pii/S2452109418300708
work_keys_str_mv AT kaleighndokemd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT lainebowmanmaotr quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT yelizavetashnaydermd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT xingleishenmd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT minditennapelphd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT sufimarythomasphd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT prakashneupanemd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT hungwenyehphd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema
AT chriselominskamd quantitativeclinicaloutcomesoftherapyforheadandnecklymphedema